These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7217343)

  • 1. Synergistic effects of probucol and cholestyramine to lower serum cholesterol.
    Boyden TW; Totman L
    J Clin Pharmacol; 1981 Jan; 21(1):48-51. PubMed ID: 7217343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose colestipol plus probucol for hypercholesterolemia.
    Dujovne CA; Chernoff SB; Krehbiel P; Jackson B; DeCoursey S; Taylor H
    Am J Cardiol; 1984 Jun; 53(11):1514-8. PubMed ID: 6375337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
    Sommariva D; Bonfiglioli D; Tirrito M; Pogliaghi I; Branchi A; Cabrini E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of individualized long-term therapy with niacin and probucol in reduction of serum cholesterol.
    Cohen L; Morgan J
    J Fam Pract; 1988 Feb; 26(2):145-50. PubMed ID: 3339318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of familial hypercholesterolemia in childhood: diet and cholestyramine resin for 24 to 36 months.
    Glueck CJ; Tsang RC; Fallat RW; Mellies M
    Pediatrics; 1977 Mar; 59(3):433-41. PubMed ID: 840563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effects of probucol and cholestyramine in familial type II hyperlipoproteinaemia.
    Pasquali R; Biso P; Parenti M; Melchionda N
    Lancet; 1981 Jun; 1(8234):1368. PubMed ID: 6113336
    [No Abstract]   [Full Text] [Related]  

  • 7. Probucol treatment decreases serum concentrations of diet-derived antioxidants.
    Elinder LS; Hådell K; Johansson J; Mølgaard J; Holme I; Olsson AG; Walldius G
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1057-63. PubMed ID: 7627696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of cholestyramine and probucol in the treatment of familial hypercholesterolaemia.
    Jones DB; Simpson HC; Slaughter P; Lousley S; Carter RD; Cobbe SM; Mann JI
    Atherosclerosis; 1984 Oct; 53(1):1-7. PubMed ID: 6388586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probucol with colestipol in the treatment of hypercholesterolemia.
    Dujovne CA; Krehbiel P; Decoursey S; Jackson B; Chernoff SB; Pitterman A; Garty M
    Ann Intern Med; 1984 Apr; 100(4):477-82. PubMed ID: 6367578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of probucol on xanthomata regression in familial hypercholesterolemia.
    Yamamoto A; Matsuzawa Y; Yokoyama S; Funahashi T; Yamamura T; Kishino B
    Am J Cardiol; 1986 Jun; 57(16):29H-35H. PubMed ID: 3728307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of probucol treatment on the susceptibility of low density lipoprotein isolated from hypercholesterolemic patients to become oxidatively modified in vitro.
    Regnström J; Walldius G; Carlson LA; Nilsson J
    Atherosclerosis; 1990 May; 82(1-2):43-51. PubMed ID: 2360919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of probucol and cholestyramine combination therapy in severe familial hypercholesterolaemia.
    Jackson JM; Lee HA
    Atherosclerosis; 1984; 51(2-3):189-97. PubMed ID: 6743378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hypercholesterolemia.
    Kane JP; Havel RJ
    Annu Rev Med; 1986; 37():427-35. PubMed ID: 3518611
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol Quantitative Regression Swedish Trial (PQRST): a status report.
    Walldius G; Carlson LA; Erikson U; Olsson AG; Johansson J; Mölgaard J; Nilsson S; Stenport G; Kaijser L; Lassvik C
    Am J Cardiol; 1988 Jul; 62(3):37B-43B. PubMed ID: 3293415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
    Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J
    Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholestyramine plus pectin in treatment of patients with familial hypercholesterolemia.
    Schwandt P; Richter WO; Weisweiler P; Neureuther G
    Atherosclerosis; 1982 Sep; 44(3):379-83. PubMed ID: 7150399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probucol, cholestyramine, and serum cholesterol.
    Mann JI
    Lancet; 1981 Aug; 2(8243):422. PubMed ID: 6115188
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin in hyperlipidemic patients treated with probucol.
    Sasaki S; Nakagawa M; Nakata T; Endo N; Miyao K; Kitamura K; Fukuyama M; Kitani T; Yamada C
    Cardiology; 1997; 88(2):160-5. PubMed ID: 9096917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia].
    Carlson LA; Olsson AG; Orö L; Rössner S
    Lakartidningen; 1974 Sep; 71(36):3289-91. PubMed ID: 4605566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.